Literature DB >> 4034514

Relative sensitivity of the fecal occult blood test and flexible sigmoidoscopy in detecting polyps.

R Y Demers, L E Stawick, P Demers.   

Abstract

A group of 1,002 male pattern and model makers, an occupational group at high risk for colorectal cancers, was screened for the presence of polyps and malignancies of the lower gastrointestinal tract. Flexible sigmoidoscopy and serial fecal occult blood testing were both performed on 988 of the participants, and 165 were found to have at least one colorectal polyp. Only 3% of all men with visualized polyps showed Hemoccult-positive stools. Only 2 (4%) of the 51 men with histologically proven adenomatous polyps were Hemoccult positive. Adenomatous polyps of 1 cm or greater in diameter are malignant 8% of the time. This study concludes that the fecal occult blood test sensitivity in detecting colorectal polyps is unacceptably low. It should be supplemented by more rigorous procedures, especially in populations at high risk for colorectal cancer.

Entities:  

Mesh:

Year:  1985        PMID: 4034514     DOI: 10.1016/0091-7435(85)90020-9

Source DB:  PubMed          Journal:  Prev Med        ISSN: 0091-7435            Impact factor:   4.018


  4 in total

1.  Immunodiscrimination of colorectal neoplasia using MUC1 antibodies: discrepant findings in tissue versus stool.

Authors:  P J Limburg; D A Ahlquist; J A Gilbert; J J Harrington; G G Klee; P C Roche
Journal:  Dig Dis Sci       Date:  2000-03       Impact factor: 3.199

Review 2.  The pros and cons of fecal occult blood testing for colorectal neoplasms.

Authors:  J B Simon
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

Review 3.  Colorectal carcinoma and Haemoccult. A study of its value in mass screening using meta-analysis.

Authors:  J Windeler; J Köbberling
Journal:  Int J Colorectal Dis       Date:  1987-11       Impact factor: 2.571

4.  Colorectal cancer and potential predictors of never screened for faecal occult blood test: a narrative review.

Authors:  Mohd Fazeli Sazali; Syed Sharizman Syed Abdul Rahim; Firdaus Hayati; Mohd Nazri Mohd Daud; Richard Avoi; Azizan Omar; Azman Atil; Muhammad Aklil Abd Rahim; Mohd Faizal Madrim; Khalid Mokti; Abdul Rahman Ramdzan; Zulkhairul Naim Sidek Ahmad; Andee Dzulkarnaen Zakaria; Mohd Firdaus Che Ani; Aini Fahriza Ibrahim; Zahir Izuan Azhar; Mohammad Saffree Jeffree; Mohd Rohaizat Hassan
Journal:  J Public Health Res       Date:  2021-08-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.